Rossari Biotech has informed that the Annual General Meeting (AGM) of the Members of Rossari Biotech (the Company) was held on Friday, September 17, 2021 at 11:00 AM through Vioeo Conferencing (VC)/ Other Audio Visual Means (OA VM). The meeting was held in compliance with the General Circular Numbers 22/2020, 14/2020, 17/2020 and 39/2020 issued by the Ministry of Corporate Affairs and Circular Number SEBI/HO/CFD/CMDI/CIR/P/2020/79 and SEBI/HO/CFD/CMD2/CIR/P/2021/11 dated January 15, 2021 issued by the Securities and Exchange Board of lndia (SEBI) and as per the applicable provisions of the Companies Act, 2013 and the Rules made thereunder. In compliance with Regulation 30 and 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), it enclosed the following; Summary of proceedings as required under Regulation 30 of the Listing Regulations; Voting Results as required under Regulation 44 of the Listing Regulations; Consolidated Scrutinizer's Report dated September 17, 2021 on remote e-voting and e-voting at the AGM.
The above information is a part of company’s filings submitted to BSE.
